AKRX Related Earnings News
-
Akorn, Inc. (AKRX) Misses Q1 on Top and Bottom
-
Akorn, Inc. (AKRX) Tops Q4 EPS by 1c
-
Akorn (AKRX) Guides FY13 adj.-EPS Below Views, Revs In-Line; Reaffirms FY12
-
Akorn, Inc. (AKRX) Tops Q3 EPS by 1c; Reaffirms FY12 Outlook
-
Leerink Swann Starts Akorn (AKRX) at Outperform
-
Akorn, Inc. (AKRX) Reports In-Line Q2 EPS; Adjusts FY12 Outlook, EPS Now Below Views
-
Akorn (AKRX) to Restate Q1 Financials on Kilitch Drugs Accounting Issue
-
Needham & Company Maintains a 'Buy' on Akorn (AKRX); New Product Outlook Affords Upward Bias
-
Akorn, Inc. (AKRX) Tops Q1 EPS by 2c; Reaffirms Outlook
-
Needham & Company Maintains a 'Buy' on Akorn (AKRX); Strong Tailwinds Drive 4Q11 Top-Line Upside; Pipeline Looks Good
-
Akorn, Inc. (AKRX) Tops Q4 EPS by 2c
-
Akorn (AKRX) Issues Weak FY12 EPS, Revs Outlook
-
Akorn, Inc. (AKRX) Tops Q3 EPS by 6c, Tweaks FY11 Guidance
-
Akorn, Inc. (AKRX) Posts Q2 EPS of 17c; Guides FY11 Revs Above
-
Akorn, Inc. (AKRX) Tops Q1 EPS by 1c; Raises FY11 Sales Outlook
-
Akorn Inc. (AKRX) Tops Q4 EPS Views; Guides FY11 Revs
-
Akorn Inc. (AKRX) Posts Q3 EPS of $0.04, Beats Views; Increases FY10 Revs Outlook
-
Akorn Inc. (AKRX) Posts Q2 Loss of $0.10, Wider than Views; Guides FY10 EPS
-
Akorn (AKRX) Reports Q1 EPS of $0.04; Raises FY10 Sales Guidance
-
Akorn Inc. (AKRX) Posts Q4 Loss of $0.03, 1c Wider Y/Y; Guides FY10 Revs
-
Akorn (AKRX) Posts Q3 Loss of $0.06, Beats By 2c
-
Akorn (AKRX) Reports Wider Q2 Loss
-
Akorn (AKRX) Tops Q3 EPS by 2c
-
Akorn, Inc. (AKRX) Reports Mixed Q2 Results
-
Akorn (AKRX) Sees Q2 Sales Exceeding Analyst Estimates by 15%
-
Akorn (AKRX) Misses Q1 EPS by 1c
-
Akorn, Inc. (AKRX) Misses Q4 EPS by 1c
-
Akorn, Inc. (AKRX) Misses Q2 EPS by 1c, Comments on Q3 Revenues
Back to AKRX Stock Lookup
